210 likes | 315 Views
Alopecia Areata is a common autoimmune skin disease, which causes hair loss on the scalp, face and at times on other areas of the body.<br>
E N D
Alopecia Areata 01 Alopecia Areata is a common autoimmune skin disease, which causes hair loss on the scalp, face and at times on other areas of the body. 02 The affected hair follicles are attacked by a person’s own immune system (white blood cells) which results in seizing of the hair growth stage. 03 Alopecia Areata begins with one or more patches which may be small, round, smooth on the scalp that can progress to total scalp hair loss or complete body hair loss. 04 People who develop Alopecia Areata can be of any age group, both sexes and all ethnic groups. It appears during childhood and can be different for people. • DelveInsight © 2019 | All rights reserved
Alopecia Areata Epidemiology All races are affected equally by alopecia areata and no increase in prevalence has been found. Alopecia Areata prevalence in the general population is estimated to be 0.1-0.2%. • Approx. 6.8 million people have or will develop alopecia areata at some point in their lives in the US. • Alopecia Areata affects approx. 2% of the general population at some • point during their lifetime in 2017. Alopecia Areata is common among children and 2.5 million people suffer in United States. • DelveInsight © 2019 | All rights reserved
Alopecia AreataMarket Standard Alopecia Areata treatment includes immune-modulators, corticosteroids, and vasodilators that are available as oral and systemic formulations. Steroids and immunotherapy are the current leading Alopecia Areata treatments.. Currently there is no cure and no FDA-approved alopecia treatments. Alopecia areata is the most common form of alopecia and is characterized by patchy scalp baldness. Genetics is the major factor driving the growth of alopecia areata drugs market across the globe. Apart from that, the rising prevalence of cancer and its treatment methods such as chemotherapy, leads to heavy hair loss that results into the increase demand of hair loss therapies. Extensive research and development activities of pharmaceutical companies for developing Alopecia Areata therapies will significantly impact the market • DelveInsight © 2019 | All rights reserved
Alopecia AreataEmerging Drugs and Companies ATI-502 (Drugs) ENERGI-F701 PF-06651600 and PF-06700841 CTP-543 (Companies) • DelveInsight © 2019 | All rights reserved
Complete Information For complete information on Alopecia Areata Market Insights, Epidemiology & Market Forecast-2028 please click the link below CLICK HERE OR Write Us At info@delveinsight.com • DelveInsight © 2019 | All rights reserved • DelveInsight © 2019 | All rights reserved
About DelveInsight Mission 2 1 3 About To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. • DelveInsight © 2019 | All rights reserved
Services by DelveInsight PharmDelve Forecasting OpportunityAssessment Consulting ReportStore MarketIntelligence Competitive Analysis Pipeline • DelveInsight © 2019 | All rights reserved
Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2019 | All rights reserved
Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2019 | All rights reserved